Rothschild & CO Asset Management Us Inc. Heron Therapeutics, Inc. Transaction History

Rothschild & CO Asset Management Us Inc.

$6.56 Billion
Q4 2022

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$4.63 - $9.94 $6.39 Million - $13.7 Million	-1,379,846 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$8.35 - $12.6 $2.55 Million - $3.85 Million	305,321 Added 28.41%	1,379,846 $12.6 Million
Q3 2021 Nov 09, 2021	SELL	$10.13 - $15.0 $397,784 - $589,020	-39,268 Reduced 3.53%	1,074,525 $11.5 Million
Q2 2021 Aug 16, 2021	BUY	$13.27 - $18.48 $1.01 Million - $1.4 Million	75,998 Added 7.32%	1,113,793 $17.3 Million
Q1 2021 May 14, 2021	SELL	$14.49 - $20.72 $4.56 Million - $6.53 Million	-314,959 Reduced 23.28%	1,037,795 $16.8 Million
Q4 2020 Feb 08, 2021	SELL	$14.61 - $22.14 $3.77 Million - $5.71 Million	-257,845 Reduced 16.01%	1,352,754 $28.6 Million
Q3 2020 Nov 09, 2020	BUY	$13.67 - $17.77 $15.1 Million - $19.6 Million	1,102,196 Added 216.8%	1,610,599 $23.9 Million
Q2 2020 Aug 10, 2020	BUY	$10.89 - $21.47 $69,870 - $137,751	6,416 Added 1.28%	508,403 $7.48 Million
Q1 2020 May 14, 2020	BUY	$10.23 - $24.56 $4.73 Million - $11.4 Million	462,236 Added 1162.83%	501,987 $5.89 Million
Q4 2019 Feb 12, 2020	SELL	$17.42 - $26.61 $32,070 - $48,989	-1,841 Reduced 4.43%	39,751 $934,000
Q3 2019 Nov 08, 2019	BUY	$16.36 - $21.39 $62,249 - $81,388	3,805 Added 10.07%	41,592 $769,000
Q2 2019 Jul 25, 2019	BUY	$16.93 - $26.22 $156,890 - $242,980	9,267 Added 32.49%	37,787 $702,000
Q1 2019 May 08, 2019	SELL	$23.15 - $28.34 $569,536 - $697,220	-24,602 Reduced 46.31%	28,520 $697,000
Q4 2018 Feb 05, 2019	SELL	$22.03 - $32.01 $8,481 - $12,323	-385 Reduced 0.72%	53,122 $1.38 Million
Q3 2018 Nov 13, 2018	BUY	$30.0 - $40.85 $1.61 Million - $2.19 Million	53,507 New	53,507 $1.69 Million

Others Institutions Holding HRTX

# of Institutions

180

Shares Held

121M

Call Options Held

80.4K

Put Options Held

94.9K

Rubric Capital Management LP New York, NY

26.7M
Shares

$28.6 Million
1.48% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

8.85M
Shares

$9.47 Million
0.03% of portfolio
Vanguard Group Inc Valley Forge, PA

8.72M
Shares

$9.33 Million
0.0% of portfolio
Black Rock Inc. New York, NY

8.33M
Shares

$8.91 Million
0.0% of portfolio
Velan Capital Investment Management LP Alpharetta, GA

6.99M
Shares

$7.48 Million
28.8% of portfolio

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $127M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild & CO Asset Management Us Inc., based on Form 13F filings with the SEC.

News

Stay updated on Rothschild & CO Asset Management Us Inc. with notifications on news.

Account